# SAVIENT PHARMACEUTICALS INC

SAVIENT PHARMACEUTICALS INC is a company headquartered in East Brunswick, NJ, United States.

## Company overview

- **Legal name:** SAVIENT PHARMACEUTICALS INC
- **Former names in filing history:** BIO TECHNOLOGY GENERAL CORP (1995-06-13 to 2003-06-06)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** East Brunswick, NJ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000722104

## About

SAVIENT PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000722104, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2013-04-01, it reported annual revenue of USD 18,023,000; net income of USD -118,312,000; total assets of USD 119,206,000 for the fiscal period ended 2012-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2012 (period ended 2012-12-31)

- **Revenue:** $18.0M (USD 18,023,000)
- **Net income:** -$118.3M (USD -118,312,000)
- **Total assets:** $119.2M (USD 119,206,000)
- **Cash and equivalents:** $50.3M (USD 50,332,000)
- **Operating cash flow:** -$114.7M (USD -114,745,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $9.6M (USD 9,565,000)
- **Net income:** -$102.0M (USD -102,027,000)
- **Total assets:** $197.1M (USD 197,116,000)
- **Cash and equivalents:** $114.1M (USD 114,094,000)
- **Operating cash flow:** -$116.8M (USD -116,836,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2010 (period ended 2010-12-31)

- **Revenue:** $4.0M (USD 4,028,000)
- **Net income:** -$73.1M (USD -73,109,000)
- **Total assets:** $77.6M (USD 77,618,000)
- **Cash and equivalents:** $44.8M (USD 44,791,000)
- **Operating cash flow:** -$52.4M (USD -52,378,000)
- **Later filings:** Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2014-05-30 — period 2014-05-30 — 8-K
- Form 8-K — filed 2014-05-20 — period 2014-05-19 — FORM 8-K
- Form 8-K — filed 2014-04-17 — period 2014-04-17 — FORM 8-K
- Form 8-K — filed 2014-03-21 — period 2014-03-20 — 8-K
- Form 8-K — filed 2014-03-18 — period 2014-03-18 — 8-K
- Form 8-K — filed 2014-02-21 — period 2014-02-20 — 8-K
- Form 8-K — filed 2014-02-11 — period 2014-02-10 — FORM 8-K
- Form 8-K — filed 2014-01-22 — period 2014-01-21 — FORM 8-K
- Form 8-K — filed 2014-01-10 — period 2014-01-08 — FORM 8-K
- Form 8-K — filed 2014-01-07 — period 2014-01-06 — 8-K
- Form 8-K — filed 2013-12-31 — period 2013-12-30 — FORM 8-K
- Form 8-K — filed 2013-12-20 — period 2013-12-20 — FORM 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/savient-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology